Opioid Use in Children with Inflammatory Bowel Disease-related Arthritis

Overview

Journal Clin Exp Rheumatol

Specialty Rheumatology

Date 2023 Apr 21

PMID 37083174

Authors

Atiye O Bilgic Dagci

Joyce C Chang

Rui Xiao

Andrew B Grossman

Pamela F Weiss

Affiliations

Soon will be listed here.

Abstract

Objectives: Concomitant arthritis may increase risk of chronic opioid use in youngsters with IBD. We aimed to assess trends and clinical features associated with opioid use in children with IBD-related arthritis.

Methods: Adolescents under 18 years of age with IBD-related arthritis, at least 1 year of continuous enrolment, and at least 1 pharmacy claim in the Truven Health MarketScan Claims and Encounter Database were included. Subjects were identified using previously validated algorithms consisting of ICD codes, pharmacy claims and procedure codes. The primary outcome was chronic opioid exposure. Temporal trends in opioid exposure were tested using the Cuzick-Wilcoxon test. The association of chronic opioid use and baseline covariates in the IBD and IBD-arthritis cohorts were examined using multivariable logistic regression models.

Results: 14,943 adolescents with IBD, 480 of whom had arthritis, were included. Chronic opioid use was non-trivial in youngsters with IBD-related arthritis, higher than that of total IBD cohort (12.3% vs. 5%) and remained stable over the years of study. Using multivariable regression, joint pain and arthritis were significantly associated with chronic opioid exposure in young people with IBD. Among IBD-related arthritis patients older age, public insurance, gastrointestinal surgery, hospitalisation and psychiatric comorbidities were significantly associated with chronic opioid use.

Conclusions: Chronic opioid use in adolescents with IBD-related arthritis was higher than that of total IBD cohort but stable over the years of study. Future study is needed to explore ways to optimise non-narcotic pain management strategies and ensuring appropriate use of opioids when necessary.

Citing Articles

Impact of chronic opioid use on acute health care utilization in children with IBD and arthritis: a retrospective cohort study.

Dagci A, Jiang S, Chang J, Grossman A, Xiao R, Weiss P BMC Pediatr. 2024; 24(1):711.

PMID: 39511521 PMC: 11542491. DOI: 10.1186/s12887-024-05206-y.

References

Lichtenstein G, Feagan B, Cohen R, Salzberg B, Diamond R, Chen D . Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol. 2006; 4(5):621-30. DOI: 10.1016/j.cgh.2006.03.002. View

Edwards J, Radford-Smith G, Florin T . Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics. J Gastroenterol Hepatol. 2002; 16(11):1235-8. DOI: 10.1046/j.1440-1746.2001.02468.x. View

Derfalvi B, Boros K, Szabo D, Bozsaki G, Cseh A, Rudas G . Joint involvement, disease activity and quality of life in pediatric Crohn's disease - a cross-sectional study. Pediatr Rheumatol Online J. 2022; 20(1):6. PMC: 8801094. DOI: 10.1186/s12969-022-00664-z. View

Ye Y, Manne S, Treem W, Bennett D . Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016. Inflamm Bowel Dis. 2019; 26(4):619-625. DOI: 10.1093/ibd/izz182. View

Hartong W, Arvanitakis C, Skibba R, KLOTZ A . Treatment of toxic megacolon. A comparative review of 29 patients. Am J Dig Dis. 1977; 22(3):195-200. DOI: 10.1007/BF01072276. View

Srinath A, Walter C, Newara M, Szigethy E . Pain management in patients with inflammatory bowel disease: insights for the clinician. Therap Adv Gastroenterol. 2012; 5(5):339-57. PMC: 3437534. DOI: 10.1177/1756283X12446158. View

Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G . Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019; 67(5152):1419-1427. PMC: 6334822. DOI: 10.15585/mmwr.mm675152e1. View

Goldstick J, Guy G, Losby J, Baldwin G, Myers M, Bohnert A . Changes in Initial Opioid Prescribing Practices After the 2016 Release of the CDC Guideline for Prescribing Opioids for Chronic Pain. JAMA Netw Open. 2021; 4(7):e2116860. PMC: 8278262. DOI: 10.1001/jamanetworkopen.2021.16860. View

Evans J, McMahon A, Murray F, McDevitt D, MacDonald T . Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut. 1997; 40(5):619-22. PMC: 1027164. DOI: 10.1136/gut.40.5.619. View

10.

Kefalakes H, Stylianides T, Amanakis G, Kolios G . Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?. Eur J Clin Pharmacol. 2009; 65(10):963-70. DOI: 10.1007/s00228-009-0719-3. View

11.

Dowell D, Haegerich T, Chou R . CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep. 2016; 65(1):1-49. DOI: 10.15585/mmwr.rr6501e1. View

12.

Dalal R, Palchaudhuri S, Snider C, Gitelman Y, Brahmbhatt M, Mull N . A Multimodal Intervention Using Nonopioid Analgesics Is Associated With Reduced Intravenous Opioid Exposure Among Hospitalized Patients With Inflammatory Bowel Diseases. Am J Gastroenterol. 2020; 115(9):1474-1485. DOI: 10.14309/ajg.0000000000000806. View

13.

Qian Z, Alyono J, Jin M, Cooperman S, Cheng A, Balakrishnan K . Opioid Prescribing Patterns Following Pediatric Tonsillectomy in the United States, 2009-2017. Laryngoscope. 2020; 131(5):E1722-E1729. DOI: 10.1002/lary.29159. View

14.

Gan S, Beck P . A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am J Gastroenterol. 2003; 98(11):2363-71. DOI: 10.1111/j.1572-0241.2003.07696.x. View

15.

Dotson J, Hyams J, Markowitz J, LeLeiko N, Mack D, Evans J . Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr. 2010; 51(2):140-5. DOI: 10.1097/MPG.0b013e3181ca4db4. View

16.

Sutherland T, Wunsch H, Pinto R, Newcomb C, Brensinger C, Gaskins L . Association of the 2016 US Centers for Disease Control and Prevention Opioid Prescribing Guideline With Changes in Opioid Dispensing After Surgery. JAMA Netw Open. 2021; 4(6):e2111826. PMC: 8196343. DOI: 10.1001/jamanetworkopen.2021.11826. View

17.

Chumpitazi C, Rees C, Camp E, Bernhardt M . Decreased Opioid Prescribing in a Pediatric Emergency Department After the Rescheduling of Hydrocodone. J Emerg Med. 2016; 52(4):547-553. DOI: 10.1016/j.jemermed.2016.08.026. View

18.

Dagci A, Chang J, Brandon T, Goheer H, Weiss P . Clinical features, treatment patterns and short-term outcomes of children with inflammatory bowel disease evaluated in rheumatology clinic. Clin Exp Rheumatol. 2022; 40(5):1045-1051. DOI: 10.55563/clinexprheumatol/2xhxrk. View

19.

Carvalho R, Abadom V, Dilworth H, Thompson R, Oliva-Hemker M, Cuffari C . Indeterminate colitis: a significant subgroup of pediatric IBD. Inflamm Bowel Dis. 2006; 12(4):258-62. DOI: 10.1097/01.MIB.0000215093.62245.b9. View

20.

Buckley L, Xiao R, Perman M, Grossman A, Weiss P . Psoriasis Associated With Tumor Necrosis Factor Inhibitors in Children With Inflammatory Diseases. Arthritis Care Res (Hoboken). 2019; 73(2):215-220. PMC: 8176628. DOI: 10.1002/acr.24100. View